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20S Abstracts June Supplement 2014iliac artery, and G3: 51 HA preservation by BBT (iliac limb
endograft (ILE) $ 20 mm in Ø).
Results: Median follow-up was 54 months (33/99/75
months), and the technical success rate was 100%. Early
(0%/0.7%/0%) and late (0%/1.4%/2%) related mortality
rates, as well as postoperative aneurysm rupture (0%/
0.7%/2%) rates, were similar among the three groups (P ¼
NS). Permanent buttock claudication (PBC; 1.9%/13.5%/
2%; P ¼ .0006) and late type II endoleak rates (1.9%/
17%/2%; P < .0004) were signiﬁcantly higher in G2. Iliac
limb migration (ILM; 1.9%/0%/9.8%; P < .0001) and late
type IB endoleak rates (0%/0%/7.8%; P < .0001) were
signiﬁcantly higher in G3. Type III endoleak rates did not
differ among the groups (1.9%/4.3%/2.0%; P ¼ NS). Iliac
limb occlusion (5.7/7.1/3.9) and reintervention rates
(7.7%/11%/15.9%) failed to reach statistical signiﬁcance
(P ¼NS). Most complications and reinterventions occurred
within a median follow-up of 18 months. According to
multivariate statistical analysis (Cox regression model), bilat-
eral HAEwas associated with PBC (P¼ .03) and late type II
endoleak (P ¼ .04). BBT (ILE $ 24 mm in Ø) was associ-
ated with ILM (P¼ .01) and late type IB endoleak (P¼ .01).
Conclusions: HAI and BBT are associated with
greater complication rates compared with the ST for the
treatment of complex aortoiliac aneurysms.
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Objectives: Secondary aneurysmal degeneration of the
thoracoabdominal aorta after acute aortic dissection is a
complex scenario. Open repair carries a high surgical risk,
and thoracic endovascular aortic repair (TEVAR) is only
feasible when the aneurysm is limited to the thoracic aorta.
We present our experience with fenestrated/branched
TEVAR (F/Br-TEVAR) in the treatment of postdissection
thoracoabdominal aortic aneurysms (TAAAs).
Methods: A prospectively maintained database
including all patients with postdissection TAAAs who un-
derwent F/Br-TEVAR within the period January 2010
to December 2013 was evaluated for initial technical
success, operative mortality and morbidity, late survival,
endoleak, aneurysm diameter regression, renal function,
and reintervention during follow-up (FU).
Results: A total of 19 patients (15 male; mean age,
65.2 6 7.6 years) were treated. Technical success was
100%. Two (10.5%) patients died #30 days postopera-
tively, one of multiple organ failure and one of cardiac
decompensation. Temporary spinal cord ischemia occurred
in two patients (10.5%), with no case of permanent para-
plegia. Mean FU was 10 6 8 months. There was one
late death, aneurysm unrelated. Renal function impairmentoccurred in one patient (5.3%). Endoleak was diagnosed in
eight patients (42%) during FU, including three type Ib
sidebranch endoleaks and ﬁve type II endoleaks. Three of
ﬁve type II endoleaks resolved spontaneously. Reinterven-
tion was required in three patients (15.8%), all for type Ib
endoleak. Mean aneurysm sac regression was 7.2 6 8 mm,
with a false lumen thrombosis rate of 65%.
Conclusions: F/Br-TEVAR is feasible for patients
with a postdissection TAAA. It is associated with additional
technical challenges and need for reintervention. F/Br-
TEVAR seems to lead to favorable aneurysm remodeling.
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Objectives: This study assessed midterm results of
aortic diameter changes of type B aortic dissection after
thoracic endovascular aortic repair (TEVAR).
Methods: Between January 2002 and June 2008, 91
patients with type B aortic dissection underwent TEVAR
and were followed up by computed tomography angio-
graphy (CTA) in our center. The CTA images were used
to measure the diameters of aortic, true lumen (TL), and
false lumen (FL). Three measurement levels, including A,
B, and C, were established for the entire aorta in advance.
Level A represented the point located at pulmonary artery
bifurcate, level B was located by projecting the ﬁrst axial
section passing through the diaphragm, and level C was
located by projecting the ﬁrst section passing under the
left main renal artery. FL thrombosis was analyzed accord-
ing to the same three levels.
Results: After TEVAR, diameters of aortic and FL
decreased, whereas TL diameters increased on level A
and B signiﬁcantly. During the follow-up, aortic segments
with a thrombosed FL manifested no substantial diameter
changes on these two levels. Patent FL caused the increase
of substantial diameter on level C. Aneurysmal dilatation
was developed on abdominal aorta 2 years after TEVAR.
Conclusions: The midterm results of endovascular
repair of acute type B dissection is encouraging. A decrease
in FL diameters and an increase in TL diameters was noted
in the thoracic aorta in most patients. Persistent ﬂow into
the FL, mainly due to entry tears at the abdominal level, was
the cause of increasing of aortic, TL and FL diameters. Close
follow-up is mandatory for patients whose FLs are patent.
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Objectives: To review current choices and late results
of aberrant right subclavian artery aneurysms (ARSAA)
repair.
Methods: All consecutive ARSAA repairs from 2006
to 2013 in seven centers were reviewed. End points were
30-day and late mortality, reintervention rates, and
ARSAA-related deaths.
Results: Included were 21 ARSAA repairs (57%
males; mean age, 67 years). Three ruptures (14%) required
emergency treatment, and 12 (57%) were symptomatic for
dysphagia (33%), dysphonia (24%), and pain (19%). Eight
cases presented thoracic aortic aneurysm, two with intra-
mural hematomas, and one with acute type B aortic dissec-
tion. Mean ARSAA diameter was 42 mm; a single bicarotid
common trunk was present in 38% of cases. Most patients
received hybrid procedures (71%), consisting of single (two
cases), bilateral (12 cases) subclavian-to-carotid transposi-
tion or bypass, or ascending aorta to subclavian by pass
(one case) plus thoracic endografting (thoracic endovascu-
lar aortic repair [TEVAR]); 19% of cases underwent open
repair and 9% simple TEVAR with ARSA overstenting.
Perioperative death occurred in two patients (9%): in one
case after TEVAR in ruptured ARSAA, requiring second-
ary sternotomy and aortic bending, and due to multiorgan
failure after a hybrid procedure in an elective case. Mean
follow-up was 316 20 months. Estimates of Kaplan-Meier
36-month survival was 90%. Late ARSAA-related death
occurred in one case due to aortobronchial ﬁstula with
continuing backﬂow from distal ARSAA and previous
TEVAR. At computed tomography controls, 1 type I
and 1 type II endoleak were detected; the latter required
a sacotomy reintervention. ARSAA-related death was
statistically more frequent after TEVAR, a procedure
reserved for ruptures, compared with open or hybrid re-
pairs (P ¼ .01).
Conclusions: Hybrid repair is the preferred therapeu-
tic option for patients presenting with ARSAA. Midterm
results show high rates of clinical success with low risk of
reintervention. Simple endografting presents high risk of
related death. These ﬁndings underline the importance of
achieving complete sealing, to avoid treatment failures.
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Objectives: The VA Open Versus Endovascular
Repair of AAA (OVER) study is the only federally funded
randomized control trial in the United States comparing
open vs endovascular aneurysm repair (EVAR) in stan-
dard-risk patients with infrarenal abdominal aortic aneu-
rysm (AAA). This subanalysis is to identify risk factors
and long-term outcome of endoleaks in patients treated
with EVAR in the OVER cohort.
Methods: The OVER trial randomized 881 patients,
and 439 received successful EVAR. Logistic regression
analysis was used to identify predictors for endoleaks and
secondary interventions. Kaplan-Meier survival analysis,
longitudinal plots, and generalized linear mixed models
methods were used to describe time to endoleak detection,
resolution, or death.
Results: A total of 135 (31%) patients developed 187
endoleaks over a mean follow-up of 6.2 6 2.4 years. Five
aneurysms went on to rupture. There was no difference
in survival between the patients who developed endoleaks
and those who did not. The 187 endoleaks included 76%
type II, 12% type I, 3% type III, 3% type IV, and 6% inde-
terminate. Initial aneurysm size and age >75 years pre-
dicted the presence of endoleaks (P < .001), whereas
neck length and angulation were not associated with endo-
leak development. The presence of endoleaks is associated
with lack of aneurysm shrinkage (P < .001). Fifty-three
percent of endoleaks resolved spontaneously, and 31%
received secondary interventions. The initial aneurysm
size independently predicted a need for secondary interven-
tion (P < .001). Delayed type II endoleaks (detected >1
year after EVAR) were associated with aneurysm enlarge-
ment compared with the early counterpart. There was no
difference in aneurysm size or length of survival between
type II and other types of endoleaks.
Conclusions: We present one of the most comprehen-
sive and longest follow-up analyses of patients treated with
aortic endografts in a randomized control trial. Endoleaks
are common, and the presence of endoleaks negatively im-
pacts sac shrinkage. Delayed type II endoleaks are associ-
ated with late sac enlargement.
